oxytocin-mediated gaba inhibition delivery attenuates autism pathogenesis rodent offspring 
report oxytocin-mediated neuroprotective g-aminobutyric acid gaba excitatory-inhibitory shift delivery abolished valproate fragile x rodent models autism delivery subsequently hippocampal neurons models elevated intracellular chloride levels increased excitatory gaba enhanced glutamatergic activity elevated gamma oscillations maternal pretreatment bumetanide restored offspring control electrophysiological behavioral phenotypes conversely blocking oxytocin signaling naive mothers produced offspring electrophysiological behavioral autistic-like features results suggest chronic deficient chloride regulation rodent models autism stress importance oxytocin-mediated gabaergic inhibition delivery process data validate amelioration observed bumetanide oxytocin point common pathways drug-induced genetic rodent model autism 
